With a 100% penetrance at 12 months of age, the TCL1-tg mouse transgenic model is highly predisposed to the development of a leukemia characterized by cell immunophenotype and behaviors that are similar to human CLL [30, 31]. This evidence concerns the gene TG and B-cell chronic lymphocytic leukemia.